Top 5 Blue Chip Stocks To Buy Right Now

Retirement investing is not what it used to be. In the old days, one could just invest in the safe stocks to buy, in blue chips, in a nice ladder of bonds, and do just fine.

Alas, the market has significantly changed. Much of this is due to the historically low interest rates weve had.

The problem with the Federal Reserves attempt to goose the economy is that it killed bond yields, forcing retired investors further out onto the risk curve, making it difficult to find safe stocks to buy. That has pushed stock prices far higher than they should be, if one subscribes (as I do) to the Peter Lynch theory that a stocks price should reflect its net income growth rate to be added to a list of stocks to buy.

Top 5 Blue Chip Stocks To Buy Right Now: Tetra Technologies, Inc.(TTI)

Advisors’ Opinion:

  • [By Lee Jackson]

    This small-cap oilfield services play has some big upside potential. Tetra Technologies Inc. (NYSE: TTI) is a diversified oil and gas services company, with the bulk of its revenue derived from drilling and completion fluids, as well as contract compression services by way of its 42% stake in CSI Compressco.

  • [By Stephan Byrd]

    Tetra Technologies (NYSE: TTI) and Chaparral Energy (OTCMKTS:CHPE) are both small-cap oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 5 Blue Chip Stocks To Buy Right Now: Omeros Corporation(OMER)

Advisors’ Opinion:

  • [By ]

    One such company is Omeros Corporation (Nasdaq: OMER). The company is a small-cap biopharma headquartered in Seattle, Washington. The company develops small-molecule and protein therapeutics for application against inflammation, coagulopathies, and disorders of the central nervous system.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Max Byerly]

    ValuEngine downgraded shares of Omeros (NASDAQ:OMER) from a buy rating to a hold rating in a report issued on Wednesday morning.

    Several other research analysts also recently commented on OMER. Zacks Investment Research raised shares of Omeros from a sell rating to a hold rating in a research note on Wednesday. HC Wainwright set a $34.00 price target on shares of Omeros and gave the stock a buy rating in a research note on Thursday, May 3rd. BidaskClub raised shares of Omeros from a sell rating to a hold rating in a research note on Wednesday, May 9th. Maxim Group set a $25.00 target price on shares of Omeros and gave the stock a buy rating in a research note on Sunday, May 13th. Finally, Wedbush reaffirmed a hold rating and issued a $20.00 target price (up from $19.00) on shares of Omeros in a research note on Wednesday, May 16th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Omeros currently has a consensus rating of Hold and an average price target of $26.00.

  • [By Chris Lange]

    Omeros Corp. (NASDAQ: OMER) is expected to release data from its Phase 2 study of OMS721/IgAN in patients not taking steroids (U.S. cohort). Shares of Omeros closed Friday at $18.14. The consensus analyst target is $36.40, and the 52-week range is $8.36 to $25.20.

Top 5 Blue Chip Stocks To Buy Right Now: Kyocera Corporation(KYO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Kyocera (NYSE:KYO) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kyocera earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 44.7168933477613 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Anders Bylund]

    Shares of Japanese materials giant Kyocera(NYSE:KYO) gained 12.1% in April 2018, according to data from S&P Global Market Intelligence. The stock rode a strong fourth-quarter report to these gains despite zero coverage in the financial press.

  • [By Max Byerly]

    Media coverage about Kyocera (NYSE:KYO) has trended somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kyocera earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 44.4825472854626 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Blue Chip Stocks To Buy Right Now: China HGS Real Estate, Inc.(HGSH)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 5 Blue Chip Stocks To Buy Right Now: Schweitzer-Mauduit International Inc.(SWM)

Advisors’ Opinion:

Leave a Reply

Your email address will not be published. Required fields are marked *